Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00590759 · ClinicalTrials.gov registry record · NA
Evaluation of the GORE TAG Thoracic Endoprosthesis in the Treatment of Aneurysms
A NA study, sponsored by W.L.Gore & Associates.
- Completed
- Registry status
- NA
- Development phase
- 150
- Enrollment target
NCT00590759 is a NA study that has completed, run by W.L.Gore & Associates. The registered enrollment target is 150 participants.
The verdict
NCT00590759, a NA study, has completed, sponsored by W.L.Gore & Associates.
- COMPLETED
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
Study Summary
The purpose of this post-approval study is to evaluate the long-term performance of the GORE TAG® Thoracic Endoprosthesis (TAG device) in the primary treatment of descending thoracic aortic (DTA) aneurysms
Interventions
- DEVICE GORE TAG® Thoracic Endoprosthesis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2005-08 |
| Est. Completion | 2013-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00590759
The ClinicalTrials.gov registry entry for NCT00590759 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is W.L.Gore & Associates, which has 53 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GORE TAG® Thoracic Endoprosthesis is the first listed.
NCT00590759 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00590759 about?
NCT00590759 is a clinical study titled "Evaluation of the GORE TAG Thoracic Endoprosthesis in the Treatment of Aneurysms". The purpose of this post-approval study is to evaluate the long-term performance of the GORE TAG® Thoracic Endoprosthesis (TAG device) in the primary treatment of descending thoracic aortic (DTA) aneurysms
What is the current status of trial NCT00590759?
This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2005-08. Estimated completion is 2013-04.
What interventions are being tested in trial NCT00590759?
The interventions under investigation include: GORE TAG® Thoracic Endoprosthesis (DEVICE).
Who is sponsoring clinical trial NCT00590759?
This trial is sponsored by W.L.Gore & Associates, which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.